Boston Scientific Posts Loss
90989
The medical device maker reported a third-quarter loss of $272 million on charges related to acquisitions and asset sales, as the companyâs top-selling stent continued to slump.
547264
Credit Suisse First Boston lowered estimates for Analog Devices (nyse: ADI - news - people ) after the maker of integrated circuits provided disappointing guidance.
715189
Boston Scientific said Thursday that three of its subsidiaries had agreed to pay $16.75 million and extend the warranty on some of its heart devices as part of a settlement with state attorneys general.
253054
A jury in Texas has ruled that Boston Scientificâs drug-coated stents infringe a 1997 patent issued to a radiologist in Princeton, N.J., and has awarded the inventor $431 million in damages, Boston Scientific said Tuesday. The suit by the patent holder, Dr. Bruce N. Saffran, did not seek to halt sales of the stents.
586414
Boston Scientific Corp. said Wednesday it expects overall third-quarter sales will miss analyst expectations as preliminary August sales of its Taxus heart device, which was involved in
200231
A Texas jury has ruled that Boston Scientificâs drug-coated stents infringe a 1997 patent issued to a radiologist and has awarded the inventor $431 million in damages, Boston Scientific said.
556891
Boston Scientific Corp. , saddled with debt and a depressed share price since buying Guidant Corp., said on Monday it may sell a minority stake in its endosurgery business for more than $1 billion in a public offering.
311263
Boston Scientific Corp. BSX.N, whose  Taxus heart device has been involved in a major recall, said on  Wednesday preliminary August sales of the device slowed to $200  million from $207 million reported in July, and issued an  outlook that was below Wall Street estimates.
139261
Boston Scientific Corp. said yesterday it has won back the market share that its flagship cardiac stent system held before three safety recalls reduced doctors&#39; orders of the product.
658871
Boston Scientific Corp. , the medical device maker, eliminated 55 jobs in Marlborough last month, according to the state Executive Office of Labor and Workforce Development. Company spokesman Paul Donovan said the Natick firm made the cuts after deciding to pull the plug on its Endovations program, an effort to develop a new single-use endoscope with an integrated ...
614065
By Steve Johnson, San Jose Mercury News, Calif.  Jan. 31--Financially burdened by its purchase in November of two companies, Gilead Sciences of Foster City today reported a net loss of $1.67 billion dollars for the fourth quarter of last year.
115320
Shares of Boston Scientific Corp. (BSX.N: Quote, Profile, Research) slid more than 3 percent in premarket trading on Wednesday after reporting that sales of its Taxus stent slowed
477052
Advanced Micro Devices  (AMD), the world's second-largest maker of computer microprocessors, posted a wider quarterly loss on Thursday due to a $1.68 billion charge from its purchase of graphics chipmaker ATI.
536287
Boston Scientific Corp. BSX.N on   Thursday issued preliminary sales and earnings results for the   third quarter below Wall Street expectations and its shares   fell nearly 4 percent in after-hours trading.
690947
The maker of digital video recorders reported a net loss of $17.7 million in the second quarter, which included an $11.2 million inventory write-off.
369322
For the period that ended Dec. 31, the company reported a loss of $16 million, or 11 cents a share, in contrast to a profit of $18 million, or 12 cents a share, in the period a year earlier.
153744
The chip maker reported a net loss of $396 million, larger than Wall Street expected, but sales were up 23 percent on strong personal-computer demand.